Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Masiá, Mar ^a   Robledano, Catalina ^a   De La Tabla, Victoria Ortiz ^b   Antequera, Pedro ^b   Lumbreras, Blanca ^c   Hernández, Ildefonso ^c   Gutiérrez, Félix ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; CD14 ANTIGEN; CD163 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; D DIMER; HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INTEGRASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RALTEGRAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATATION; HEPATITIS C; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SERODIAGNOSIS; AGED; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; COINFECTION; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84939483323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105442     Document Type: Article

References (28)

1. Neuhaus J, Angus B, Kowalska JD, La Rosa A, Sampson J, et al. (2010) Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS 24: 697-706.
2. Masiá M, Padilla S, Álvarez D, López JC, Santos I, et al. (2013) Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy. AIDS 27: 181-189.
3. Deeks SG, Phillips AN (2009) HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 338: a3172.
4. Aldaz P, Moreno-Iribas C, Egüés N, Irisarri F, Floristan Y, et al. (2011) Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health 11: 300.
5. McComsey GA, Kitch D, Sax PE, Tierney C, Jahed NC, et al. (2014) Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202. J Acquir Immune Defic Syndr 65: 167-174
6. Miller CJ, Baker JV, Bormann AM, Erlandson KM, Huppler Hullsiek K, et al. (2014) Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy. PLoS One; 9:e95061
7. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, et al. (2010) Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201: 1788-1795.
8. Alcaide ML, Parmigiani A, Pallikkuth S, Roach M, Freguja R, et al. (2013) Immune Activation in HIV-Infected Aging Women on Antiretrovirals-Implications for Age-Associated Comorbidities: A Cross-Sectional Pilot Study. PLoS One 8:e63804.
9. Marchetti G, Bellistri GM, Borghi E, Tincati C, Ferramosca S, et al. (2008) Microbial Translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22: 2035-2038.
10. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, et al. (2008) Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 197: 126-133. (Pubitemid 351263476)
11. Masiá M, Robledano C, Ortiz de la Tabla V, Antequera P, López N, et al. (2013) Increased Carotid Intima-Media Thickness Associated with Antibody Responses to Varicella-Zoster Virus and Cytomegalovirus in HIV-Infected Patients. PLoS One; 8:e64327.
12. Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, et al. (2006) Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 20: 2275-2283. (Pubitemid 44789529)
13. Hechter RC, Budoff M, Hodis HN, Rinaldo CR, Jenkins FJ, et al. (2012) Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study. Atherosclerosis 223: 433-436.
14. Giuliani M, Cordiali-Fei P, Castilletti C, Di Carlo A, Palamara G, et al. (2007) Incidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections. BMC Infect Dis 7: 143.
15. Crabtree KL, Wojcicki JM, Minhas V, Smith DR, Kankasa C, et al. (2014) Risk factors for early childhood infection of human herpesvirus-8 in Zambian children: the role of early childhood feeding practices. Cancer Epidemiol Biomarkers Prev 23: 300-8.
16. Hannachi N, Ben Fredj N, Samoud S, Ferjani A, Khlif A, et al. (2012) Seroprevalence and risk factors of human herpes virus 8 infection in Central-East Tunisia. Pathol Biol (Paris) 60: 282-6.
17. Gutiérrez F, Masiá M, Padilla S, Ramos JM, Bernal E, et al. (2006) Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension: A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hipertensión. J Clin Virol 37: 79-82. (Pubitemid 44441970)
18. Grahame-Clarke C, Alber DG, Lucas SB, Miller R, Vallance P (2001) Association between Kaposi's sarcoma and atherosclerosis: implications for gammaherpesviruses and vascular disease. AIDS 15: 1902-1904. (Pubitemid 32939261)
19. Masiá M, Padilla S, García N, Jarrin I, Bernal E, et al. (2010) Endothelial function is impaired in HIV-infected patients with lipodystrophy. Antivir Ther; 15: 101-110.
20. Gutiérrez F, Bernal E, Padilla S, Hernández I, Masiá M (2008) Relationship between ankle-brachial index and carotid intima-media thickness in HIV-infected patients. AIDS 22: 1369-1371.
21. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843. (Pubitemid 30165206)
22. Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43: 52-58. (Pubitemid 27024390)
23. Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, et al. (2013) Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood 122: 4189-98.
24. Uldrick TS, Wang V, O'Mahony D, Aleman K, Wyvill KM, et al. (2010) An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis 51: 350-8.
25. Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, et al. (2011) T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 203: 452-463.
26. Cassol E, Misra V, Holman A, Kamat A, Morgello S, et al. (2013) Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. BMC Infect Dis 13: 203.
27. Martínez E, D'Albuquerque PM, Llibre JM, Gutierrez F, Podzamczer D, et al. (2012) Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. AIDS 26: 2315-26.
28. Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, et al. (2000) Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 38: 2174-2180. (Pubitemid 30414334)